IGF1R
Showing 1 - 25 of >10,000
IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung
Completed
- Non Small Cell Lung Cancer
- Protein expression by immunohistochemistry and immunofluorescence
-
Rozzano, Milan, ItalyIstituto Clinco Humanitas
Sep 8, 2022
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
-
Los Angeles, California
- +1 more
Mar 17, 2022
Role of LncRNA H19 in The Regulation of IGF-1R Expression
Completed
- Hepatocellular Carcinoma
- +2 more
- Blood sample collection
-
Mansoura, Dakahliya, Egypt
- +1 more
Apr 5, 2022
HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker
Active, not recruiting
- HER2/Neu Negative
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, Washington
- +1 more
Jan 11, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)
Recruiting
- Breast Cancer Female
- +7 more
- DC1 Vaccine
- WOKVAC Vaccine
-
Tampa, Florida
- +6 more
Apr 4, 2022
Malignant Glioma, Tumors Trial in Philadelphia (IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion
Completed
- Malignant Glioma
- Neoplasms
- IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours.
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Oct 5, 2020
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023
Molecular Imaging Trial in Harbin (68Ga-NODAGA-ZIGF-1R:4:40)
Unknown status
- Molecular Imaging
- 68Ga-NODAGA-ZIGF-1R:4:40
-
Harbin, Heilongjiang, ChinaTOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
Feb 20, 2020
The AgRP and GH/IGF-1 Axis in Children
Not yet recruiting
- Growth Hormone Deficiency
- (no location specified)
Dec 8, 2022
Acute Kidney Injury (Nontraumatic), Pneumoperitoneum Trial (IGF-1)
Not yet recruiting
- Acute Kidney Injury (Nontraumatic)
- Pneumoperitoneum
- IGF-1
- (no location specified)
Nov 8, 2022
Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)
Not yet recruiting
- Glioblastoma Multiforme
- Glioblastoma
- IGV-001 Cell Immunotherapy
- +3 more
-
Newark, Delaware
- +22 more
Jun 24, 2022
Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low
Recruiting
- Growth Retardation
- (enteral feeding volume/ total fluid volume)*100%
-
Xingtai, He Bei, ChinaWei Guo
Oct 4, 2023
Insulin Growth Factor I Deficiency, IGF1 Deficiency, Executive Function Disorder Trial in Seville (HIIT, HIIT+PA, CON)
Recruiting
- Insulin Growth Factor I Deficiency
- +2 more
- HIIT
- +2 more
-
Seville, SpainEducation Faculty
Nov 30, 2022
Sarcopenia, Geriatric, Muscle Mass Trial in Palembang (Ophiochepalus striatus extract, Placebo)
Recruiting
- Sarcopenia
- +4 more
- Ophiochepalus striatus extract
- Placebo
-
Palembang, South Sumatera, IndonesiaMohammad Hoesin Central General Hospital
May 11, 2023
Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)
Not yet recruiting
- Thyroid Eye Disease
- VRDN-001 10 mg/kg Drug:
- (no location specified)
Sep 7, 2023
22q13 Deletion Syndrome, Phelan-McDermid Syndrome Trial in New York (Insulin-Like Growth Factor-1 (IGF-1), Normal saline)
Completed
- 22q13 Deletion Syndrome
- Phelan-McDermid Syndrome
- Insulin-Like Growth Factor-1 (IGF-1)
- Normal saline
-
New York, New YorkSeaver Austin Center, Icahn School of Medicine at Mount Sinai
Apr 18, 2022
Failure to Thrive, Infection, Bacterial, Growth Faltering Trial in Surabaya (high calorie formula (oral nutritional
Recruiting
- Failure to Thrive
- +2 more
- high calorie formula (oral nutritional supplement/ONS)
-
Surabaya, East Java, IndonesiaHusada Utama Hospital
Oct 2, 2022
Relation Between Serum IGF-1 & BMI In Acne Vulgaris
Not yet recruiting
- Evaluation of Serum Level of Insulin Like Growth Factor 1
- (no location specified)
Aug 16, 2022
Breast Cancer, Brain Cancer, Gastrointestinal Cancers Trial in Chicago (IGF-Methotrexate conjugate)
Completed
- Breast Cancer
- +7 more
- IGF-Methotrexate conjugate
-
Chicago, IllinoisUniversity of Illinois at Chicago
Aug 20, 2019
Recovery in Post-stroke Rehabilitation
Completed
- Ischemic Stroke
-
Lodz, PolandMedical University of Lodz
Feb 20, 2023
Cancer, Overweight and Obesity Trial (Aerobic Exercise)
Not yet recruiting
- Cancer
- Overweight and Obesity
- Aerobic Exercise
- (no location specified)
Dec 13, 2022